ClinicalTrials.Veeva

Menu

An Observational Study on Treatment Compliance by Children Treated With Growth Hormone (IMPACT)

Novo Nordisk logo

Novo Nordisk

Status

Withdrawn

Conditions

Growth Hormone Deficiency in Children
Growth Hormone Disorder

Treatments

Behavioral: No treatment given

Study type

Observational

Funder types

Industry

Identifiers

NCT01068639
U1111-1113-2490 (Other Identifier)
GH-3787

Details and patient eligibility

About

This study is conducted in Europe. This observational study aims at evaluating compliance with growth hormone treatment in children and identifying factors influencing compliance.

Sex

All

Ages

Under 18 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Child treated for at least one year with growth hormone any growth hormone product
  • Followed by the participating paediatrician for at least 1 year.

Exclusion criteria

  • Refusal to participate
  • Child and/or parent unable to give consent or fill out the questionnaires
  • Child participating in a therapeutic trial

Trial design

0 participants in 1 patient group

A
Treatment:
Behavioral: No treatment given

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems